Search

everythinglearnresearchcommunity

for

Search:↓

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair follicle stem cells prevent melanocyte stem cells from differentiating by controlling retinoic acid levels.

Dark skin has stronger barriers and structure due to specific gene activity.

Biological therapy boosts the immune system to effectively fight melanoma.

Different types of human skin cells respond uniquely to various colors and doses of light, which could lead to specialized light treatments for skin conditions.

The Wnt/β-catenin pathway can activate melanocyte stem cells and may help regenerate hair follicles.

Travoprost can help eyelash growth but may cause darkening around the eyes.

Estrogens and progesterone are key in regulating melasma pigmentation.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

Micropigmentation is a cosmetic tattooing technique for hiding skin issues and creating permanent makeup, but it can have side effects.

Drugs can be incorporated into hair based on their chemical properties and hair pigmentation.

Androgens increase pigmentation in certain hamster skin areas, but estrogens can reverse this effect.

Melatonin may protect skin from radiation, but its effects on aging and hair growth are unclear.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Certain drugs can change hair color, either lightening or darkening it.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

Accurate prediction of eye, hair, and skin color in Latin American populations requires region-specific models and ethical guidelines.

A new mouse model effectively mimics vitiligo for research and drug testing.

Mesenchymal stem cells may help reduce melanin in UV-exposed mice.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Tranexamic acid turns white hair brown in certain mice by affecting specific proteins.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.